[go: up one dir, main page]

US20170042661A1 - Vascular prosthesis - Google Patents

Vascular prosthesis Download PDF

Info

Publication number
US20170042661A1
US20170042661A1 US15/269,906 US201615269906A US2017042661A1 US 20170042661 A1 US20170042661 A1 US 20170042661A1 US 201615269906 A US201615269906 A US 201615269906A US 2017042661 A1 US2017042661 A1 US 2017042661A1
Authority
US
United States
Prior art keywords
diameter
tubular portion
generally tubular
vascular prosthesis
prosthesis according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US15/269,906
Inventor
Peter Lyon Harris
Thien Voon How
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bard Peripheral Vascular Inc
Original Assignee
Bard Peripheral Vascular Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bard Peripheral Vascular Inc filed Critical Bard Peripheral Vascular Inc
Priority to US15/269,906 priority Critical patent/US20170042661A1/en
Publication of US20170042661A1 publication Critical patent/US20170042661A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/064Blood vessels with special features to facilitate anastomotic coupling
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods
    • A61B17/11Surgical instruments, devices or methods for performing anastomosis; Buttons for anastomosis
    • A61B2017/1135End-to-side connections, e.g. T- or Y-connections
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2002/068Modifying the blood flow model, e.g. by diffuser or deflector
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0073Quadric-shaped
    • A61F2230/008Quadric-shaped paraboloidal

Definitions

  • By-passes to save limbs may be required to have a relatively long length, such as the distance from the groin to below the knee, and may be required to attach to arteries that may be as small as 1 mm to 5 mm in diameter.
  • arteries may be as small as 1 mm to 5 mm in diameter.
  • prosthetic grafts of synthetic materials for example flexible tubes of polytetrafluoroethylene (PTFE).
  • U.S. Pat. No. 5,156,619 discloses a vascular prosthesis comprising a tube of material other than autologous vascular tissue, the tube having an enlarged end formation for surgical connection direct to an opening formed in an artery, the formation having a heel and a toe at opposite ends of a first longer diameter parallel to the axis of the tube and a second shorter transverse diameter.
  • WO 97/31591 discloses a flanged graft for end-to-side anastomosis grafting having an integral terminal flanged skirt or cuff, which facilitates an end-to-side anastomosis directly between an artery and the expanded flange bypass graft without need for an intervening venous collar or venous patch.
  • a vascular prosthesis comprising a tube of synthetic material having an end formation for surgical connection directly to an opening formed in an artery, the end formation comprising an enlarged chamber serving to promote localized movement of blood having a non-laminar nature with a shear stress inducing relationship to the arterial wall.
  • the term “non-laminar” as used herein is intended to define blood flow other than parallel to arterial walls and, in particular, includes localized laminar movement of blood having significant secondary components.
  • the proposed enlarged chamber has a convex outer wall. Further experimentation, however, has revealed that this type of vascular prosthesis, while representing an improvement on the aforementioned Miller cuff may still not be ideal for certain applications.
  • an object of the present invention is to provide an improved vascular prosthesis for use in vascular surgery.
  • a vascular prosthesis comprising a tube of material other than autologous vascular tissue, said tube having an end formation for surgical connection direct to an opening formed in an artery, said formation comprising an enlarged chamber having a heel and a toe at opposite ends of a first longer diameter parallel to the axis of the tube and a second shorter transverse diameter, characterized in that a transition between the tube and the toe is outwardly initially convex before a final concave portion, whereby said enlarged chamber serves to promote localized movement of blood having a non-laminar nature with shear stress inducing relationship to receiving arterial wall.
  • the heel of the enlarged chamber is formed at one end of the longer diameter, and the transition between the tube and the heel is preferably generally concave. Transition between the tube and opposite ends of the shorter diameter is preferably outwardly convex. It is also preferable that the tube have a narrower portion prior to transition to the enlarged chamber. It is believed that such narrowing of the tube will increase blood velocity entering the enlarged chamber of the prosthesis and hence increase shear stress in that region.
  • the grafts of the invention are preferably made of plastics material, especially polytetrafluoroethylene (PTFE).
  • the vascular prosthesis of the invention is intended to promote vertical blood flow in the region of its arterial connection in order to reduce or eliminate regions of low shear stress and regions of long residence times where blood elements can accumulate in the region of the graft connection.
  • Separation of flowing blood from the inner wall of the tube near its enlarged chamber, and associated with non-laminar flow, is preferably such as to produce a swirling action that may include locally circulatory or re-circulatory movement of blood, further preferably in the nature of or including a vortex action.
  • Such blood flow separation will usually occur directly at, as well as adjacent to, preferred acute angling of the prosthesis tube for its direct connection to the artery, which would be at least partially within the enlarged chamber.
  • a preferred end chamber of the prosthesis tube of the invention is an enlargement which produces blood flow characteristics therein that result in an increase in wall shear stress.
  • Desired non-laminar-blood flow promotion is preferably effective only in phases of cycles of blood-flow pulsing, which phases preferably alternate with other phases of more laminar flow sufficient to assist flow of all blood into the artery away from that end of the prosthesis.
  • the pulsed nature of normal blood flow involved successive time-spaced rises in pressure. Each pressure rise preferably causes both an initial relatively smooth or laminar blood flow in and out of the prosthesis-to-artery connection and a later transition into desired non-laminar blood movement.
  • the preferred non-laminar vortex type movement preferably collapses before the next pressure rise.
  • FIG. 1 is a sectional line diagram useful for explaining problems arising from simple direct connection or anastomoses of a prosthetic graft tube of synthetic material to an opening made in an artery.
  • FIG. 2 shows use of a veinous cuff interposed between a prosthetic graft tube and an artery.
  • FIG. 3 is a section through the graft of FIG. 2 showing typical blood flow therethrough.
  • FIG. 4 is a side view of a first prosthetic graft of the invention.
  • FIG. 5 is a rear view of the graft of FIG. 4 .
  • FIG. 6 is a view from below of the graft of FIG. 4 .
  • FIG. 7 is a perspective view of the graft of FIG. 4 .
  • FIG. 8 shows the graft of FIGS. 4 to 7 connected to an artery.
  • FIG. 9 is a side view of a second prosthetic graft of the invention.
  • FIG. 10 is a rear view of the graft of FIG. 9 .
  • FIG. 11 is a view from below of the graft of FIG. 9 .
  • FIG. 12 is a perspective view of the graft of FIG. 9 .
  • FIG. 13 shows the graft of FIGS. 9 to 12 .
  • FIGS. 1-3 prior art devices are depicted in FIGS. 1-3 .
  • artery 12 has an opening made by an incision at 16 .
  • Prosthetic graft tube 10 of synthetic material (for which PTFE, most usually expanded PTFE (ePTFE), is widely used in practice) is run at an acute angle or more or less parallel to the artery 12 .
  • Tube 10 is indicated cut to an angled end 18 that is end to edge sewn into the opening 16 .
  • myointimal-hyperplasia to occur later in the receiving artery 12 (see indicated development of fibrous or scare-like tissue in the toe and heel positions 11 and 13 , respectively), and also at plate position 15 opposite the opening 16 .
  • FIGS. 2 and 3 illustrate the Miller cuff, aimed at reducing such problems by using a short length of another vein, usually from still usable parts of the saphenous vein that would be used in its entirety if serviceable.
  • This short length of autologous vein typically 2 to 3 mm in diameter, is removed and opened along its length, then sutured first to an opening 36 of the artery 32 and end-to-end to itself at 39 .
  • the completed cuff 34 is trimmed and anastomoses completed at 38 to normally wider prosthetic graft tube 30 .
  • the graft tube 30 is typically made of PTFE and is at least 4 mm, preferably 6 mm if not more, in diameter.
  • FIG. 3 Typical blood flow through the Miller cuff is shown in FIG. 3 .
  • a vortex 40 is formed to increase shear stress; however at opposite sides of the cuff, low shear stress regions 42 , 44 develop where accumulation of deposits can form, resulting in intimal hyperplasia. Furthermore, where flow separates at the arterial wall opposite the cuff, a low shear stress region 46 also develops where intimal hyperplasia is possible.
  • a first vascular prosthetic graft 50 is ideally made of polytetrafluoroethylene.
  • the graft has a tubular part 52 of any desired length according to the length of the by-pass to be made using the graft and an enlargement 54 at one or both ends of the tube 52 (only one is shown).
  • the enlargement 54 has an open end of a generally oval cross-section forming a heel 56 and a toe 58 at opposite ends of the larger diameter of the open end.
  • Sides 66 of the enlargement 54 at opposite ends of the shorter diameter of the open end are generally outwardly convex.
  • the plane of the open end of the enlargement 54 and of the tube 52 are generally parallel but it should be noted that prosthetic grafts having different separations thereof may be made for use in different situations. It should be further noted that prosthetic grafts having open ends of varying longer diameters may be produced. Furthermore, the degree of curvature either to the heel or the toe may be varied from graft to graft, in order to alter blood flow characteristics through the graft connection.
  • the prosthetic graft 50 is in practice connected to an artery by forming a slit in a side of an artery 67 , opening out the slit and stitching the open end of the graft to the sides of the slit.
  • connection of the graft causes the artery to have a concave underside opposite the graft as can be seen at 68 in FIG. 8 of the drawings.
  • the length of the open end of the graft will probably be in the order of 14 to 36 mm and the width of the open end is unlikely to be less than 6 mm and probably not greater than 14 mm.
  • FIGS. 9 to 13 illustrate a variation on the prosthetic graft of the present embodiment. Like parts have been numbered similarly and only the main difference between them will now be described.
  • the tube 52 of the graft includes a narrower portion 70 prior to commencement of the enlargement.

Landscapes

  • Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

A vascular prosthesis configured for direct connection to an artery. The vascular prosthesis may include a tube of material other than autologous vascular tissue, having an end formation, which is configured for surgical connection to an opening formed in the artery, and a narrower portion prior to commencement of the end formation. The end formation may have an enlarged chamber adapted to induce a concave section in said blood vessel upon attachment thereto.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation of U.S. Patent Application Ser. No. 10/603,952, now U.S. Pat. No. 9,445,886, filed on Jun. 25, 2003, which is a continuation of U.S. Patent Application Ser. No. 09/762,761, now U.S. Pat. No. 6,589,278, filed Oct. 5, 2001, which is a 371 of International Application No. PCT/GB998/01418, filed May 15, 1998, claiming priority to United Kingdom patent application GB 9709967.5, filed May 17, 1997. This application expressly incorporates by reference the entirety of each of the above mentioned applications as if fully set forth herein.
  • BACKGROUND OF THE INVENTION
  • By-passes to save limbs may be required to have a relatively long length, such as the distance from the groin to below the knee, and may be required to attach to arteries that may be as small as 1 mm to 5 mm in diameter. Where patients have no other veins that can be used, as is often the case with patients having relevant serious conditions, the only positive alternative is to use prosthetic grafts of synthetic materials, for example flexible tubes of polytetrafluoroethylene (PTFE). Simple direct end connections or anastomosis of prosthetic graft tubes (usually run at an acute angle or more or less parallel with the artery and end cut at an angle) to side apertures in arteries, perhaps particularly arteries substantially less than 5 mm in diameter, has unfortunately been followed by formation of fibrous intimal hyperplasia, which leads to serious blood flow reduction and even stoppage. The fibrous intimal hyperplasia occurs in regions within and around the graft connection, where there is little or no shear stress between the blood flow and the graft and arterial walls.
  • It is known to use a small piece of natural vein to make a short cuff known as the Miller cuff (that is joined by surgical stitching to and between the artery opening and the end of the prosthetic graft tube. Improved success rates for indirect prosthesis-to-vein-to-artery connection, compared with direct prosthesis-to-artery, have involved reduced adverse effect from intimal hyperplasia. Contributory factors, for cuff type and other prosthesis types, have been considered and postulated as including reducing tendencies to turbulence of blood flow, and/or optimizing approximation to laminar blood flow, and/or for suppleness of the natural vein parts to aid absorption or cushioning blood pulsing. These factors have further been seen particularly as contributing to avoiding or minimizing occurrence of artery wall shear stress. However, fibrous intimal hyperplasia still occurs with the so called Miller cuff because regions of flow separation and low shear stress still occur within the cuff.
  • U.S. Pat. No. 5,156,619 discloses a vascular prosthesis comprising a tube of material other than autologous vascular tissue, the tube having an enlarged end formation for surgical connection direct to an opening formed in an artery, the formation having a heel and a toe at opposite ends of a first longer diameter parallel to the axis of the tube and a second shorter transverse diameter. WO 97/31591 discloses a flanged graft for end-to-side anastomosis grafting having an integral terminal flanged skirt or cuff, which facilitates an end-to-side anastomosis directly between an artery and the expanded flange bypass graft without need for an intervening venous collar or venous patch.
  • It has been proposed to provide a vascular prosthesis comprising a tube of synthetic material having an end formation for surgical connection directly to an opening formed in an artery, the end formation comprising an enlarged chamber serving to promote localized movement of blood having a non-laminar nature with a shear stress inducing relationship to the arterial wall. The term “non-laminar” as used herein is intended to define blood flow other than parallel to arterial walls and, in particular, includes localized laminar movement of blood having significant secondary components. The proposed enlarged chamber has a convex outer wall. Further experimentation, however, has revealed that this type of vascular prosthesis, while representing an improvement on the aforementioned Miller cuff may still not be ideal for certain applications.
  • Therefore, it is an object of the present invention is to provide an improved vascular prosthesis for use in vascular surgery.
  • BRIEF SUMMARY OF THE INVENTION
  • According to the present' invention there is provided a vascular prosthesis comprising a tube of material other than autologous vascular tissue, said tube having an end formation for surgical connection direct to an opening formed in an artery, said formation comprising an enlarged chamber having a heel and a toe at opposite ends of a first longer diameter parallel to the axis of the tube and a second shorter transverse diameter, characterized in that a transition between the tube and the toe is outwardly initially convex before a final concave portion, whereby said enlarged chamber serves to promote localized movement of blood having a non-laminar nature with shear stress inducing relationship to receiving arterial wall.
  • The heel of the enlarged chamber is formed at one end of the longer diameter, and the transition between the tube and the heel is preferably generally concave. Transition between the tube and opposite ends of the shorter diameter is preferably outwardly convex. It is also preferable that the tube have a narrower portion prior to transition to the enlarged chamber. It is believed that such narrowing of the tube will increase blood velocity entering the enlarged chamber of the prosthesis and hence increase shear stress in that region. The grafts of the invention are preferably made of plastics material, especially polytetrafluoroethylene (PTFE).
  • The vascular prosthesis of the invention is intended to promote vertical blood flow in the region of its arterial connection in order to reduce or eliminate regions of low shear stress and regions of long residence times where blood elements can accumulate in the region of the graft connection. Separation of flowing blood from the inner wall of the tube near its enlarged chamber, and associated with non-laminar flow, is preferably such as to produce a swirling action that may include locally circulatory or re-circulatory movement of blood, further preferably in the nature of or including a vortex action. Such blood flow separation will usually occur directly at, as well as adjacent to, preferred acute angling of the prosthesis tube for its direct connection to the artery, which would be at least partially within the enlarged chamber. A preferred end chamber of the prosthesis tube of the invention is an enlargement which produces blood flow characteristics therein that result in an increase in wall shear stress.
  • Desired non-laminar-blood flow promotion is preferably effective only in phases of cycles of blood-flow pulsing, which phases preferably alternate with other phases of more laminar flow sufficient to assist flow of all blood into the artery away from that end of the prosthesis. The pulsed nature of normal blood flow involved successive time-spaced rises in pressure. Each pressure rise preferably causes both an initial relatively smooth or laminar blood flow in and out of the prosthesis-to-artery connection and a later transition into desired non-laminar blood movement. The preferred non-laminar vortex type movement preferably collapses before the next pressure rise.
  • These and other embodiments, features and advantages of the present invention will become more apparent to those skilled in the art when taken with reference to the following more detailed description of the invention in conjunction with the accompanying drawings that are first briefly described.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a sectional line diagram useful for explaining problems arising from simple direct connection or anastomoses of a prosthetic graft tube of synthetic material to an opening made in an artery.
  • FIG. 2 shows use of a veinous cuff interposed between a prosthetic graft tube and an artery.
  • FIG. 3 is a section through the graft of FIG. 2 showing typical blood flow therethrough.
  • FIG. 4 is a side view of a first prosthetic graft of the invention.
  • FIG. 5 is a rear view of the graft of FIG. 4.
  • FIG. 6 is a view from below of the graft of FIG. 4.
  • FIG. 7 is a perspective view of the graft of FIG. 4.
  • FIG. 8 shows the graft of FIGS. 4 to 7 connected to an artery.
  • FIG. 9 is a side view of a second prosthetic graft of the invention.
  • FIG. 10 is a rear view of the graft of FIG. 9.
  • FIG. 11 is a view from below of the graft of FIG. 9.
  • FIG. 12 is a perspective view of the graft of FIG. 9.
  • FIG. 13 shows the graft of FIGS. 9 to 12.
  • DETAILED DESCRIPTION OF THE INVENTION
  • The following detailed description should be read with reference to the drawings, in which like elements in different drawings are identically numbered. The drawings, which are not necessarily to scale, depict selected preferred embodiments and are not intended to limit the scope of the invention. The detailed description illustrates by way of example, not by way of limitation, the principles of the intention. This description will clearly enable one skilled in the art to make and use the invention, and describes several embodiments, adaptations, variations, alternatives and uses of the invention, including what is presently believed to be the best mode of carrying out the invention.
  • In the drawings, prior art devices are depicted in FIGS. 1-3. Referring first to FIG. 1, artery 12 has an opening made by an incision at 16. Prosthetic graft tube 10 of synthetic material (for which PTFE, most usually expanded PTFE (ePTFE), is widely used in practice) is run at an acute angle or more or less parallel to the artery 12. Tube 10 is indicated cut to an angled end 18 that is end to edge sewn into the opening 16. Unfortunately, there is a tendency for myointimal-hyperplasia to occur later in the receiving artery 12 (see indicated development of fibrous or scare-like tissue in the toe and heel positions 11 and 13, respectively), and also at plate position 15 opposite the opening 16. This development can seriously reduce the very blood flow that it is the object of the procedure to improve. Indeed, this condition all too often progresses to complete blockage of such blood flow. These problems are pronounced as the size of the receiving artery 12 decreases, which can be as small as 1 to 5 mm for the type of distal bypasses often needed, such as from the groin to beyond the knee as is frequently necessary to save a patient's lower leg.
  • FIGS. 2 and 3 illustrate the Miller cuff, aimed at reducing such problems by using a short length of another vein, usually from still usable parts of the saphenous vein that would be used in its entirety if serviceable. This short length of autologous vein, typically 2 to 3 mm in diameter, is removed and opened along its length, then sutured first to an opening 36 of the artery 32 and end-to-end to itself at 39. The completed cuff 34 is trimmed and anastomoses completed at 38 to normally wider prosthetic graft tube 30. The graft tube 30 is typically made of PTFE and is at least 4 mm, preferably 6 mm if not more, in diameter. Improvement in terms of reducing development of intimal hyperplasia was originally, and has since consistently been, attributed to the autologous vein-to-artery junction. The suppleness of the veinous tissue may also have contributed to this improvement by assisting absorption of pressure pulsing and reducing shear wall stress in the receiving artery. Wall shear stress was assumed and reported as being the major causative factor in development of intimal hyperplasia. This procedure has become popular and has been the subject of considerable development, including similar use in interconnected small arteries.
  • Typical blood flow through the Miller cuff is shown in FIG. 3. A vortex 40 is formed to increase shear stress; however at opposite sides of the cuff, low shear stress regions 42, 44 develop where accumulation of deposits can form, resulting in intimal hyperplasia. Furthermore, where flow separates at the arterial wall opposite the cuff, a low shear stress region 46 also develops where intimal hyperplasia is possible.
  • Turning to FIGS. 4 to 8 of the accompanying drawings, a first vascular prosthetic graft 50 according to the invention is ideally made of polytetrafluoroethylene. The graft has a tubular part 52 of any desired length according to the length of the by-pass to be made using the graft and an enlargement 54 at one or both ends of the tube 52 (only one is shown). The enlargement 54 has an open end of a generally oval cross-section forming a heel 56 and a toe 58 at opposite ends of the larger diameter of the open end. There is a generally outwardly concave transition 60 between the tube 52 and the heel 56 and between the tube 52 and the toe 58 a firstly convex 62 and a final concave 64 transition. Sides 66 of the enlargement 54 at opposite ends of the shorter diameter of the open end are generally outwardly convex.
  • The plane of the open end of the enlargement 54 and of the tube 52 are generally parallel but it should be noted that prosthetic grafts having different separations thereof may be made for use in different situations. It should be further noted that prosthetic grafts having open ends of varying longer diameters may be produced. Furthermore, the degree of curvature either to the heel or the toe may be varied from graft to graft, in order to alter blood flow characteristics through the graft connection. The prosthetic graft 50 is in practice connected to an artery by forming a slit in a side of an artery 67, opening out the slit and stitching the open end of the graft to the sides of the slit. It is to be noted that such connection of the graft causes the artery to have a concave underside opposite the graft as can be seen at 68 in FIG. 8 of the drawings. The length of the open end of the graft will probably be in the order of 14 to 36 mm and the width of the open end is unlikely to be less than 6 mm and probably not greater than 14 mm.
  • FIGS. 9 to 13 illustrate a variation on the prosthetic graft of the present embodiment. Like parts have been numbered similarly and only the main difference between them will now be described. In order to increase the velocity of blood flow through the graft connection to an artery, the tube 52 of the graft includes a narrower portion 70 prior to commencement of the enlargement.
  • The present invention has been described above in terms of certain preferred embodiments so that an understanding of the present invention can be conveyed. However, there are many alternative arrangements not specifically described herein but with which the present invention is applicable. Although specific features have been provided, the device of the present invention would equally be embodied by other configurations not specifically recited herein. The scope of the present invention should therefore not be limited by the embodiments illustrated, but rather it should be understood that the present invention has wide applicability with respect to vascular prostheses generally. All modifications, variations, or equivalent elements and implementations that are within the scope of the appended claims should therefore be considered within the scope of the invention.

Claims (20)

1. A vascular prosthesis comprising:
generally tubular portion that defines a blood-flow lumen and that has a luminal surface that contacts blood flowing through the lumen, and an abluminal surface that does not contact blood flowing through the lumen, wherein the luminal surface comprises a material other than vascular tissue,
wherein
the tubular portion has an end formation, the end formation comprising an enlarged chamber having a first diameter and a second diameter transverse to the axis of the generally tubular portion,
the first diameter is longer than the second diameter,
the first diameter comprising a heel and a toe,
a transition between the tubular portion the toe is outwardly initially convex before a final concave portion,
and
the enlarged chamber is adapted to induce a concave section in a blood vessel.
2. The vascular prosthesis according to claim 1 wherein the enlarged chamber is configured to promote localized movement of blood having a non-laminar nature with a shear stress inducing relationship to a wall of the blood vessel.
3. The vascular prosthesis according to claim 2 wherein a transition between the generally tubular portion and the heel is generally outwardly concave.
4. The vascular prosthesis according to claim 3 wherein opposing sides of the second diameter are generally outwardly convex.
5. The vascular prosthesis according to claim 4 further comprising a narrow section positioned between the generally tubular portion and the end formation, wherein a diameter of the narrow section is less than a diameter of the generally tubular portion.
6. The vascular prosthesis according to claim 5 the generally tubular portion having a second end formation at an end of the generally tubular portion opposite the end formation.
7. The vascular prosthesis according to claim 6 wherein the second end formation comprises a second enlarged chamber having a first diameter parallel to the axis of the generally tubular portion and a second diameter transverse to the axis of the generally tubular portion, wherein the first diameter is longer than the second diameter, the first diameter comprising a heel and a toe, wherein a transition between the generally tubular portion and the toe is outwardly initially convex before a final concave portion.
8. The vascular prosthesis according to claim 7 wherein a transition between the generally tubular portion and the heel of the second enlarged chamber is generally outwardly concave.
9. The vascular prosthesis according to claim 8 wherein opposing sides of the second diameter of the second enlarged chamber are generally outwardly convex.
10. The vascular prosthesis according to claim 9 further comprising a second narrow section positioned between the generally tubular portion and the second end formation, wherein a diameter of the second narrow section is less than a diameter of the generally tubular portion.
11. A vascular prosthesis comprising:
generally tubular portion that defines a blood-flow lumen and that has a luminal surface that contacts blood flowing through the lumen, and an abluminal surface that does not contact blood flowing through the lumen, wherein the luminal surface comprises a material other than vascular tissue,
wherein
the tubular portion has an end formation configured for surgical connection to an opening formed in a blood vessel, the end formation comprising an enlarged chamber having a first diameter parallel to the axis of the generally tubular portion and a second diameter transverse to the axis of the generally tubular portion,
the first diameter is longer than the second diameter,
the first diameter comprising a heel and a toe,
a transition between the generally tubular portion and the toe is outwardly initially convex before a final concave portion,
and
the enlarged chamber is adapted to induce a concave section in the blood vessel upon attachment of the prosthesis to the vessel.
12. The vascular prosthesis according to claim 11 wherein the enlarged chamber is configured to promote localized movement of blood having a non-laminar nature with a shear stress inducing relationship to a wall of the blood vessel.
13. The vascular prosthesis according to claim 12 wherein a transition between the generally tubular portion and the heel is generally outwardly concave.
14. The vascular prosthesis according to claim 13 wherein opposing sides of the second diameter are generally outwardly convex.
15. The vascular prosthesis according to claim 14 further comprising a narrow section positioned between the generally tubular portion and the end formation, wherein a diameter of the narrow section is less than a diameter of the generally tubular portion.
16. The vascular prosthesis according to claim 15 the generally tubular portion having a second end formation at an end of the generally tubular portion opposite the end formation.
17. The vascular prosthesis according to claim 16 wherein the second end formation comprises a second enlarged chamber having a first diameter parallel to the axis of the generally tubular portion and a second diameter transverse to the axis of the generally tubular portion, wherein the first diameter is longer than the second diameter, the first diameter comprising a heel and a toe, wherein a transition between the generally tubular portion and the toe is outwardly initially convex before a final concave portion.
18. The vascular prosthesis according to claim 17 wherein a transition between the generally tubular portion and the heel of the second enlarged chamber is generally outwardly concave.
19. The vascular prosthesis according to claim 18 wherein opposing sides of the second diameter of the second enlarged chamber are generally outwardly convex.
20. The vascular prosthesis according to claim 19 further comprising a second narrow section positioned between the generally tubular portion and the second end formation, wherein a diameter of the second narrow section is less than a diameter of the generally tubular portion.
US15/269,906 1997-05-17 2016-09-19 Vascular prosthesis Abandoned US20170042661A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US15/269,906 US20170042661A1 (en) 1997-05-17 2016-09-19 Vascular prosthesis

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GBGB9709967.5A GB9709967D0 (en) 1997-05-17 1997-05-17 Prosthetic grafts
GB9709967.5 1997-05-17
PCT/GB1998/001418 WO1998052495A1 (en) 1997-05-17 1998-05-15 Vascular prosthesis
US09/762,761 US6589278B1 (en) 1997-05-17 1998-05-15 Vascular prosthesis
US10/603,952 US9445886B2 (en) 1997-05-17 2003-06-25 Vascular prosthesis
US15/269,906 US20170042661A1 (en) 1997-05-17 2016-09-19 Vascular prosthesis

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/603,952 Continuation US9445886B2 (en) 1997-05-17 2003-06-25 Vascular prosthesis

Publications (1)

Publication Number Publication Date
US20170042661A1 true US20170042661A1 (en) 2017-02-16

Family

ID=10812426

Family Applications (3)

Application Number Title Priority Date Filing Date
US09/762,761 Expired - Lifetime US6589278B1 (en) 1997-05-17 1998-05-15 Vascular prosthesis
US10/603,952 Expired - Fee Related US9445886B2 (en) 1997-05-17 2003-06-25 Vascular prosthesis
US15/269,906 Abandoned US20170042661A1 (en) 1997-05-17 2016-09-19 Vascular prosthesis

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US09/762,761 Expired - Lifetime US6589278B1 (en) 1997-05-17 1998-05-15 Vascular prosthesis
US10/603,952 Expired - Fee Related US9445886B2 (en) 1997-05-17 2003-06-25 Vascular prosthesis

Country Status (10)

Country Link
US (3) US6589278B1 (en)
EP (1) EP1011533B1 (en)
JP (1) JP4280308B2 (en)
AT (1) ATE367127T1 (en)
AU (1) AU7441998A (en)
CA (1) CA2303802C (en)
DE (1) DE69838100T2 (en)
ES (1) ES2288763T3 (en)
GB (1) GB9709967D0 (en)
WO (1) WO1998052495A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019220322A1 (en) 2018-05-14 2019-11-21 Sabic Global Technologies B.V. Hydrogen production from aqueous formaldehyde under mild basic conditions

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6273912B1 (en) 1996-02-28 2001-08-14 Impra, Inc. Flanged graft for end-to-side anastomosis
AU723247B2 (en) * 1996-02-28 2000-08-24 Bard Peripheral Vascular, Inc. Flanged graft for end-to-side anastomosis
GB9709967D0 (en) * 1997-05-17 1997-07-09 Harris Peter L Prosthetic grafts
US9814869B1 (en) * 1999-06-15 2017-11-14 C.R. Bard, Inc. Graft-catheter vascular access system
US6821295B1 (en) * 2000-06-26 2004-11-23 Thoratec Corporation Flared coronary artery bypass grafts
JP3673744B2 (en) * 2001-09-27 2005-07-20 大晃機械工業株式会社 Vacuum pump
FR2850008A1 (en) * 2003-01-17 2004-07-23 Daniel Roux Vascular prosthesis has tube and collar for adapting to blood vessel ends of different diameters
US7998188B2 (en) * 2003-04-28 2011-08-16 Kips Bay Medical, Inc. Compliant blood vessel graft
WO2006013234A1 (en) * 2004-07-02 2006-02-09 Daniel Roux Vascular prosthesis for adapting diameter differences between two ends of a replaceable blood vessel segment
JP4964134B2 (en) 2004-08-31 2012-06-27 シー・アール・バード・インコーポレーテッド Self-sealing PTFE graft with torsion resistance
WO2006044904A2 (en) * 2004-10-15 2006-04-27 Vanderbilt University Nano- and micro-scale engineering of polymeric scaffolds for vascular tissue engineering
US20110076315A1 (en) * 2005-06-08 2011-03-31 C.R Bard, Inc. Grafts and Stents Having Inorganic Bio-Compatible Calcium Salt
ES2625807T3 (en) 2005-06-17 2017-07-20 C.R. Bard, Inc. Vascular graft with twisting resistance after clamping
US8709069B2 (en) * 2005-07-01 2014-04-29 C. R. Bard, Inc. Flanged graft with trim lines
CA2626598A1 (en) 2005-11-09 2007-05-18 C.R. Bard Inc. Grafts and stent grafts having a radiopaque marker
US7722665B2 (en) 2006-07-07 2010-05-25 Graft Technologies, Inc. System and method for providing a graft in a vascular environment
DE102006036073A1 (en) * 2006-08-02 2008-02-07 Heise, Michael, Dr.med. Vascular tubular graft
EP2079575B1 (en) 2006-10-12 2021-06-02 C.R. Bard, Inc. Methods for making vascular grafts with multiple channels
US9039758B2 (en) * 2006-12-07 2015-05-26 Stanley Batiste Bypass vascular graft
US9603695B2 (en) 2006-12-07 2017-03-28 Stanley Batiste Bypass vascular graft
US9549808B2 (en) 2006-12-07 2017-01-24 Stanley Batiste Bypass configuration and method of construction
US20130197546A1 (en) 2007-08-02 2013-08-01 Bioconnect Systems, Inc. Implantable flow connector
US8690816B2 (en) 2007-08-02 2014-04-08 Bioconnect Systems, Inc. Implantable flow connector
DE102007063265A1 (en) * 2007-12-17 2009-06-18 Aesculap Ag Woven textile vascular prosthesis
US20100121247A1 (en) * 2008-11-13 2010-05-13 Chen Yang Dialysis Graft with Thromboses Prevention Arrangement
US20120071965A1 (en) * 2010-09-17 2012-03-22 Longo Michael A Implantable graft connector
US10434293B2 (en) 2012-04-15 2019-10-08 Tva Medical, Inc. Implantable flow connector
US9314600B2 (en) 2012-04-15 2016-04-19 Bioconnect Systems, Inc. Delivery system for implantable flow connector
CA2891620C (en) 2012-08-10 2021-05-25 Abiomed, Inc. Graft anchor devices, systems, and methods
US9814563B1 (en) * 2014-04-25 2017-11-14 David M. Hoganson Hemodynamically optimized shunt
US20160007997A1 (en) * 2014-07-14 2016-01-14 Chengxiong Gu Bridge vessels-proximal anastomosis supporting device for coronary artery bypass grafting and manufacturing method thereof
CN111417361B (en) 2017-12-01 2023-08-11 C·R·巴德股份有限公司 Adjustable vascular grafts for customized inside diameter reduction and related methods
US11974748B2 (en) 2019-01-11 2024-05-07 The Regents Of The University Of Colorado System and method for attaching a fluid conduit to an anatomical structure
EP4507624A1 (en) 2022-03-23 2025-02-19 Connex Biomedical, Inc. Assembly for end-to-side anastamosis

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4530113A (en) * 1983-05-20 1985-07-23 Intervascular, Inc. Vascular grafts with cross-weave patterns

Family Cites Families (131)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2127903A (en) 1936-05-05 1938-08-23 Davis & Geck Inc Tube for surgical purposes and method of preparing and using the same
US3196194A (en) 1964-06-04 1965-07-20 Pennsylvania Fluorocarbon Co I Fep-fluorocarbon tubing process
US3492994A (en) 1967-08-25 1970-02-03 Joseph H Field Nerve holder and guide for perpendicular cutting
US3683926A (en) 1970-07-09 1972-08-15 Dainippon Pharmaceutical Co Tube for connecting blood vessels
US3713441A (en) 1970-10-22 1973-01-30 Battelle Development Corp Method of using an artery vein shunt applique
US3853462A (en) 1972-02-23 1974-12-10 Meadox Medicals Inc Compaction of polyester fabric materials
US3815608A (en) 1972-03-10 1974-06-11 East West Med Prod Retaining catheter
US3945052A (en) 1972-05-01 1976-03-23 Meadox Medicals, Inc. Synthetic vascular graft and method for manufacturing the same
US3816919A (en) 1972-06-28 1974-06-18 H Portnoy Means for cutting nerve tissue
US3826257A (en) 1972-07-14 1974-07-30 T Buselmeier Prosthetic shunt
US3805301A (en) 1972-07-28 1974-04-23 Meadox Medicals Inc Tubular grafts having indicia thereon
US3818511A (en) 1972-11-17 1974-06-25 Medical Prod Corp Medical prosthesis for ducts or conduits
US3825257A (en) 1973-10-19 1974-07-23 G Palmer Apparatus for practicing basketball throws
US3882862A (en) 1974-01-11 1975-05-13 Olga Berend Arteriovenous shunt
US3986828A (en) 1974-03-05 1976-10-19 Meadox Medicals, Inc. Polymer fabric compacting process
US6436135B1 (en) 1974-10-24 2002-08-20 David Goldfarb Prosthetic vascular graft
SU571253A1 (en) * 1975-07-11 1977-09-05 Всесоюзный научно-исследовательский и испытательный институт медицинской техники Apparatus fir suturing vessels with metal clips
JPS5230097A (en) 1975-09-02 1977-03-07 Kaneyasu Miyata Method of mounting different substitute blood vessel
US4047252A (en) 1976-01-29 1977-09-13 Meadox Medicals, Inc. Double-velour synthetic vascular graft
US4234535A (en) 1976-04-29 1980-11-18 Sumitomo Electric Industries, Ltd. Process for producing porous polytetrafluoroethylene tubings
US4279259A (en) 1976-07-06 1981-07-21 Dow Corning Corporation Mammometer
US4192312A (en) 1978-09-01 1980-03-11 Wilson Donald L Surgical incision guide means
EP0011437B1 (en) 1978-11-20 1983-06-22 Imperial Chemical Industries Plc A process for setting a product comprising electrostatically spun fibres, and products prepared according to this process
US4321914A (en) 1980-04-22 1982-03-30 W. L. Gore & Associates, Inc. Percutaneous conduit having PTFE skirt
US4309776A (en) 1980-05-13 1982-01-12 Ramon Berguer Intravascular implantation device and method of using the same
JPS6028434Y2 (en) 1980-06-16 1985-08-28 建部 容保 Artificial blood vessel
US4354495A (en) 1980-10-30 1982-10-19 Sherwood Medical Industries Inc. Method of connecting plastic tube to a plastic part
US4366819A (en) * 1980-11-17 1983-01-04 Kaster Robert L Anastomotic fitting
US4441215A (en) * 1980-11-17 1984-04-10 Kaster Robert L Vascular graft
US4387516A (en) 1980-12-22 1983-06-14 L & A, Inc. Universal insole
US4416028A (en) 1981-01-22 1983-11-22 Ingvar Eriksson Blood vessel prosthesis
US4503568A (en) * 1981-11-25 1985-03-12 New England Deaconess Hospital Small diameter vascular bypass and method
US4501263A (en) 1982-03-31 1985-02-26 Harbuck Stanley C Method for reducing hypertension of a liver
US4482516A (en) 1982-09-10 1984-11-13 W. L. Gore & Associates, Inc. Process for producing a high strength porous polytetrafluoroethylene product having a coarse microstructure
US4517687A (en) 1982-09-15 1985-05-21 Meadox Medicals, Inc. Synthetic woven double-velour graft
IT1156682B (en) 1982-10-14 1987-02-04 Pro Bio Spe Produz Biolog Spec LOW PROFILE BICUSPID ORGANIC VALVE
US4546499A (en) 1982-12-13 1985-10-15 Possis Medical, Inc. Method of supplying blood to blood receiving vessels
US4909979A (en) 1983-03-24 1990-03-20 Possis Medical, Inc. Method for making a vascular graft
US4728328A (en) 1984-10-19 1988-03-01 Research Corporation Cuffed tubular organic prostheses
US4630375A (en) 1985-05-02 1986-12-23 Spolyar John L Apparatus for gauging and determining spatial coordinates for a source of radiation to be employed in obtaining a radiograph of a patient
US4807622A (en) 1985-09-20 1989-02-28 Kato Hatsujo Kaisha, Ltd. Tube cutting and separating implement for conduit of blood or the like
US5042161A (en) 1985-10-07 1991-08-27 Joseph Hodge Intravascular sizing method and apparatus
US4712551A (en) * 1986-10-14 1987-12-15 Rayhanabad Simon B Vascular shunt
GB8625679D0 (en) 1986-10-27 1986-11-26 Ethicon Inc Synthetic vascular grafts
JPH0763489B2 (en) 1986-10-31 1995-07-12 宇部興産株式会社 Medical tube
US4743480A (en) 1986-11-13 1988-05-10 W. L. Gore & Associates, Inc. Apparatus and method for extruding and expanding polytetrafluoroethylene tubing and the products produced thereby
US4714421A (en) 1987-02-11 1987-12-22 National Tool & Manufacturing Co., Inc. Quick-switch mold set with clamp means
US4816028A (en) 1987-07-01 1989-03-28 Indu Kapadia Woven vascular graft
US4935190A (en) 1987-07-10 1990-06-19 William G. Whitney Method of making balloon retention catheter
US4840940A (en) 1987-10-21 1989-06-20 Sottiurai Vikrom S Method for reducing the occurrence of distal anastomotic intimal hyperplasia using fractionated heparin
US4872455A (en) 1987-11-25 1989-10-10 Corvita Corporation Anastomosis trimming device and method of using the same
US5110526A (en) 1988-09-22 1992-05-05 Nippon Valqua Industries, Ltd. Process for producing molded articles of polytetrafluoroethylene resin
US4944737A (en) 1988-12-14 1990-07-31 Kathryn Rowe Bloom Surgical stencil and method of using the same
US4957669A (en) 1989-04-06 1990-09-18 Shiley, Inc. Method for producing tubing useful as a tapered vascular graft prosthesis
JP2678945B2 (en) 1989-04-17 1997-11-19 有限会社ナイセム Artificial blood vessel, method for producing the same, and substrate for artificial blood vessel
US5100422A (en) 1989-05-26 1992-03-31 Impra, Inc. Blood vessel patch
DK0474748T3 (en) * 1989-05-31 1995-05-01 Baxter Int Biological flap prosthesis
US5571169A (en) 1993-06-07 1996-11-05 Endovascular Instruments, Inc. Anti-stenotic method and product for occluded and partially occluded arteries
US5156619A (en) 1990-06-15 1992-10-20 Ehrenfeld William K Flanged end-to-side vascular graft
US5078735A (en) 1990-06-18 1992-01-07 Mobin Uddin Kazi Prosthetic grafting method for bypass surgery
DE69210225T2 (en) 1991-02-14 1996-12-05 Baxter Int Manufacturing process for flexible biological tissue transplant materials
US5304220A (en) 1991-07-03 1994-04-19 Maginot Thomas J Method and apparatus for implanting a graft prosthesis in the body of a patient
US5456714A (en) * 1991-07-04 1995-10-10 Owen; Earl R. Tubular surgical implant having a locking ring and flange
JPH05192408A (en) 1991-09-06 1993-08-03 C R Bard Inc Production of expansion balloon
FR2685208B1 (en) 1991-12-23 1998-02-27 Ela Medical Sa VENTRICULAR CANNULA DEVICE.
US5540712A (en) 1992-05-01 1996-07-30 Nitinol Medical Technologies, Inc. Stent and method and apparatus for forming and delivering the same
DE4222380A1 (en) 1992-07-08 1994-01-13 Ernst Peter Prof Dr M Strecker Endoprosthesis implantable percutaneously in a patient's body
USD348618S (en) 1992-08-21 1994-07-12 Leslie Nan S Breast examination pad
CA2106523A1 (en) 1992-10-06 1994-04-07 Jude S. Sauer Surgical device to prepare body tissue for anastomosis
US5399352A (en) 1993-04-14 1995-03-21 Emory University Device for local drug delivery and methods for using the same
WO1995009585A1 (en) * 1993-10-01 1995-04-13 Imperial College Of Science, Technology & Medicine Vascular prostheses
US5443497A (en) 1993-11-22 1995-08-22 The Johns Hopkins University Percutaneous prosthetic by-pass graft and method of use
US5562617A (en) 1994-01-18 1996-10-08 Finch, Jr.; Charles D. Implantable vascular device
US5476506A (en) * 1994-02-08 1995-12-19 Ethicon, Inc. Bi-directional crimped graft
EP0766539B1 (en) * 1994-06-13 2003-05-21 Endomed, Inc. Expandable endovascular graft and method for forming the same
EP1582181A3 (en) 1994-06-27 2010-04-21 Bard Peripheral Vascular, Inc. Radially expandable polytetrafluoroethylene and expandable endovascular stents formed therewith
US5575817A (en) 1994-08-19 1996-11-19 Martin; Eric C. Aorto femoral bifurcation graft and method of implantation
US5653743A (en) * 1994-09-09 1997-08-05 Martin; Eric C. Hypogastric artery bifurcation graft and method of implantation
EP0782497B1 (en) 1994-09-23 2001-07-11 Impra, Inc. Vascular graft containing carbon and method for making same
IT1267463B1 (en) * 1994-09-27 1997-02-05 Alessandro Verona PROSTHETIC DUCT PARTICULARLY FOR THE TREATMENT OF CARDIOVASCULAR PATHOLOGIES.
US5472404A (en) 1995-02-21 1995-12-05 Volgushev; Valentin E. Method for surgical correction of vascular occlusions
US5695504A (en) 1995-02-24 1997-12-09 Heartport, Inc. Devices and methods for performing a vascular anastomosis
US5976159A (en) 1995-02-24 1999-11-02 Heartport, Inc. Surgical clips and methods for tissue approximation
US5683449A (en) 1995-02-24 1997-11-04 Marcade; Jean Paul Modular bifurcated intraluminal grafts and methods for delivering and assembling same
US5591203A (en) 1995-03-24 1997-01-07 Organ, Inc. Anastomosis cuff manipulator tool
GB9510967D0 (en) 1995-05-31 1995-07-26 Harris Peter L Vascular prostheses
US5723005A (en) 1995-06-07 1998-03-03 Herrick Family Limited Partnership Punctum plug having a collapsible flared section and method
US5752934A (en) 1995-09-18 1998-05-19 W. L. Gore & Associates, Inc. Balloon catheter device
US6287315B1 (en) 1995-10-30 2001-09-11 World Medical Manufacturing Corporation Apparatus for delivering an endoluminal prosthesis
JP2750569B2 (en) * 1995-12-07 1998-05-13 幸夫 堀口 Intravascular blood flow regulator and artificial blood vessel for bypass
US5843158A (en) 1996-01-05 1998-12-01 Medtronic, Inc. Limited expansion endoluminal prostheses and methods for their use
US6190590B1 (en) 1996-02-28 2001-02-20 Impra, Inc. Apparatus and method for making flanged graft for end-to-side anastomosis
US6273912B1 (en) 1996-02-28 2001-08-14 Impra, Inc. Flanged graft for end-to-side anastomosis
AU723247B2 (en) 1996-02-28 2000-08-24 Bard Peripheral Vascular, Inc. Flanged graft for end-to-side anastomosis
US5849036A (en) * 1996-03-29 1998-12-15 Zarate; Alfredo R. Vascular graft prosthesis
SE509388C2 (en) 1996-05-17 1999-01-18 Jan Otto Solem Branching device for a blood vessel
US5824010A (en) 1996-05-23 1998-10-20 Mcdonald; Garth R. Suture needle guide
US5800514A (en) 1996-05-24 1998-09-01 Meadox Medicals, Inc. Shaped woven tubular soft-tissue prostheses and methods of manufacturing
FR2751867B1 (en) 1996-08-05 1999-05-21 Leriche Rene Ass PROSTHESIS COLLERETTE
US5782916A (en) * 1996-08-13 1998-07-21 Galt Laboratories, Inc. Device for maintaining urinary continence
US6019788A (en) 1996-11-08 2000-02-01 Gore Enterprise Holdings, Inc. Vascular shunt graft and junction for same
US6074419A (en) 1996-12-31 2000-06-13 St. Jude Medical, Inc. Indicia for prosthetic device
US6203735B1 (en) 1997-02-03 2001-03-20 Impra, Inc. Method of making expanded polytetrafluoroethylene products
US6102884A (en) 1997-02-07 2000-08-15 Squitieri; Rafael Squitieri hemodialysis and vascular access systems
US6302908B1 (en) * 1997-03-24 2001-10-16 Juan Carlos Parodi Arterial graft device and method of positioning the same
GB9709967D0 (en) 1997-05-17 1997-07-09 Harris Peter L Prosthetic grafts
GB9710905D0 (en) 1997-05-27 1997-07-23 Imperial College Stent for blood vessel
US5950320A (en) 1997-08-29 1999-09-14 Dorsey; Thomas R. Medico-scientific measuring device
US6187033B1 (en) 1997-09-04 2001-02-13 Meadox Medicals, Inc. Aortic arch prosthetic graft
US6019768A (en) * 1997-11-18 2000-02-01 Ethicon, Inc, Suture anchor retriever and method for retrieving an implanted suture anchor
US6626939B1 (en) 1997-12-18 2003-09-30 Boston Scientific Scimed, Inc. Stent-graft with bioabsorbable structural support
US6048362A (en) 1998-01-12 2000-04-11 St. Jude Medical Cardiovascular Group, Inc. Fluoroscopically-visible flexible graft structures
US5989287A (en) 1998-05-06 1999-11-23 Av Healing Llc Vascular graft assemblies and methods for implanting same
SE517169C2 (en) 1998-10-23 2002-04-23 Prisell Ab P Template and punch to indicate as well as remove a piece of skin
US6086553A (en) 1999-07-01 2000-07-11 Akbik; Mohamad J. Arteriovenous shunt
US6821295B1 (en) 2000-06-26 2004-11-23 Thoratec Corporation Flared coronary artery bypass grafts
US6585762B1 (en) 2000-08-10 2003-07-01 Paul Stanish Arteriovenous grafts and methods of implanting the same
US6458155B1 (en) 2000-09-01 2002-10-01 Edwards Lifesciences Corporation Fresh donor heart valve sizer and method of use
JP2004529735A (en) 2001-06-18 2004-09-30 イーバ コーポレイション Prosthetic implants and their use
US6858035B2 (en) 2001-07-05 2005-02-22 Converge Medical, Inc. Distal anastomosis system
US20030014108A1 (en) 2001-07-16 2003-01-16 Lauren Janice Hansen Adjustable areola and nipple prosethesis
US7407480B2 (en) 2001-07-27 2008-08-05 Ams Research Corporation Method and apparatus for correction of urinary and gynecological pathologies, including treatment of incontinence cystocele
US20030051362A1 (en) 2001-09-14 2003-03-20 Buckman Robert F. Incision template and methods for use
US20030182815A1 (en) 2002-03-28 2003-10-02 Kimberly-Clark Worldwide, Inc. Surgical site marking system
US7160320B2 (en) 2002-04-16 2007-01-09 The International Heart Institute Of Montana Foundation Reed valve for implantation into mammalian blood vessels and heart with optional temporary or permanent support
USD496596S1 (en) 2003-04-30 2004-09-28 Robert Dalrymple Image french measuring adjunct
ITBO20030631A1 (en) 2003-10-23 2005-04-24 Roberto Erminio Parravicini VALVULAR PROSTHETIC EQUIPMENT, IN PARTICULAR FOR HEART APPLICATIONS.
US7989490B2 (en) 2004-06-02 2011-08-02 Cordis Corporation Injectable formulations of taxanes for cad treatment
CA2600711C (en) 2005-03-15 2014-07-08 Surmodics, Inc. Compliant polymeric coatings for insertable medical articles
US8709069B2 (en) 2005-07-01 2014-04-29 C. R. Bard, Inc. Flanged graft with trim lines
WO2009086458A1 (en) 2007-12-27 2009-07-09 C.R. Bard. Inc. Vascular graft prosthesis having a reinforced margin for enhanced anastomosis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4530113A (en) * 1983-05-20 1985-07-23 Intervascular, Inc. Vascular grafts with cross-weave patterns

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019220322A1 (en) 2018-05-14 2019-11-21 Sabic Global Technologies B.V. Hydrogen production from aqueous formaldehyde under mild basic conditions

Also Published As

Publication number Publication date
US6589278B1 (en) 2003-07-08
ATE367127T1 (en) 2007-08-15
EP1011533A1 (en) 2000-06-28
DE69838100D1 (en) 2007-08-30
US9445886B2 (en) 2016-09-20
GB9709967D0 (en) 1997-07-09
AU7441998A (en) 1998-12-11
CA2303802C (en) 2007-04-03
ES2288763T3 (en) 2008-01-16
JP4280308B2 (en) 2009-06-17
CA2303802A1 (en) 1998-11-26
DE69838100T2 (en) 2008-04-10
EP1011533B1 (en) 2007-07-18
US20040064181A1 (en) 2004-04-01
JP2002510221A (en) 2002-04-02
WO1998052495A1 (en) 1998-11-26

Similar Documents

Publication Publication Date Title
US20170042661A1 (en) Vascular prosthesis
JP3506253B2 (en) Percutaneous prosthetic joint
US6221101B1 (en) Controlled vortex inducing vascular prosthesis
US10182902B2 (en) Differential dilation stent and method of use
US5989287A (en) Vascular graft assemblies and methods for implanting same
US6306164B1 (en) Short body endoprosthesis
EP1791497B1 (en) Side branch stent graft
US20220039938A1 (en) Flow modification devices in body lumens
US7651526B2 (en) Vascular graft
US6315752B1 (en) Implantable bypass device
US20060229710A1 (en) Vascular graft
MXPA99010589A (en) Vascular prosthesis
Seth et al. Revascularization of a thrombosed, previously stented aorto‐renal graft using combined directional atherectomy and AngioJet thrombectomy
IE20040465A1 (en) A vascular graft
Hallock Vein coupler to simplify the end-to-side microanastomosis
Hans Salvage of apparently occluded femoropopliteal autogenous vein graft (case report)
IE20060230A1 (en) A vascular graft
MXPA99006482A (en) Luminal endoprosthesis for ramification

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION